MedTrace Logo

Effects of Beta-blockade on Platelet Aggregation in Acute Coronary Syndrome

NCT02809820 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-03-31

No results posted yet for this study

Summary

The Investigators will test the hypothesis that nonselective beta-blockers would have a more pronounced effect on platelet aggregation than selective beta-blockers in patients with acute coronary syndrome treated with dual anti platelet therapy.

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

Carvedilol

Patients randomized to this group will receive carvedilol at the highest dose tolerated

DRUG

Metoprolol

Patients randomized to this group will receive metoprolol at the highest dose tolerated

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Principal Investigators

  • Giovanni Esposito, MD PhD · Federico II University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02809820 on ClinicalTrials.gov